학술논문
Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Document Type
Article
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia September 2019 19(9):570-578
Subject
Language
ISSN
2152-2650